High Sensitivity and Precision High-Temperature Reversed-Phase LC Analysis of Bevacizumab for Intact Bioanalysis of Therapeutic Monoclonal Antibodies

DOI Web Site Web Site 8 Citations 25 References
  • YAMADA Tomohiro
    School of Pharmaceutical Sciences, University of Shizuoka
  • MIZUNO Hajime
    School of Pharmaceutical Sciences, University of Shizuoka
  • Zhe MIN Jun
    Key Laboratory for Natural Resource of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University
  • TOYO’OKA Toshimasa
    School of Pharmaceutical Sciences, University of Shizuoka
  • TODOROKI Kenichiro
    School of Pharmaceutical Sciences, University of Shizuoka

Search this article

Abstract

<p>We optimized several analytical conditions for more sensitive and precise HT-RPLC analysis of the therapeutic monoclonal antibody (mAb), bevacizumab. Specifically, we (1) optimized the sample preparation process to reduce adsorption and aggregation of bevacizumab, (2) introduced a sample concentration process using a centrifugal ultrafiltration unit to increase detection sensitivity, and (3) used another therapeutic mAb as an internal standard to improve analytical precision. The optimized method for bevacizumab analysis was shown to have low detection and quantification limits of 0.010 and 0.032 µg/mL, respectively, good correlation coefficients (r2 > 0.9997), and good intra- and inter-day precisions within < 12.0 %. This study provides an important methodology for the intact bioanalysis of therapeutic mAbs, not merely their LC measurement.</p>

Journal

  • CHROMATOGRAPHY

    CHROMATOGRAPHY 39 (1), 21-26, 2018

    The Society for Chromatographic Sciences

Citations (8)*help

See more

References(25)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top